Siemens HealthineersSiemens Healthcare that has an exceptional track record of engineering and scientific excellence will now be known by the brand name Siemens Healthineers. The new name indicates the company’s pioneering spirit and its engineering expertise in the healthcare industry. The company consistently develops innovative clinical solutions that enable healthcare providers to offer efficient, high quality patient care.

As part of its Vision 2020 strategy, Siemens AG announced nearly two years ago that its healthcare business would be separately managed as a company within the company with a new organizational setup.

According to Bernd Montag, the CEO of the company, “Our new brand is a bold signal for our ambition and expresses our identity as a people company – 45,000 employees worldwide who are passionate about empowering healthcare providers to optimally serve their patients. Going forward as Siemens Healthineers, we will leverage this expertise to provide a wider range of customized clinical solutions that support our customers’ business holistically. We are confident in our capability to become their inspiring partner on our customers’ journey to success.”

In the rapidly changing healthcare industry, companies are discovering new ways to improve people’s health. Moreover, the structures, incentives, and processes are radically changing to support the growing patient population. Based on strong dedication to engineering excellence, this reliable manufacturer undertook a pioneering role in helping healthcare professionals improve care and extend it to more patients.

Features that distinguish Siemens include:

  • Product heritage
  • Global network of customers
  • Healthcare expertise
  • Project experience
  • Service skills

As engineers and pioneers of healthcare, Siemens Healthineers is expected to continue to strengthen its leading portfolio across the medical imaging and laboratory diagnostics business while adding new offerings such as managed services, consulting and digital services as well as further technologies in the growing market for therapeutic and molecular diagnostics. However, the name of the legal entities will remain unchanged.

In order to discover and translate new opportunities and possibilities in the healthcare system, the company is working closely with its partners and also aims to broaden and deepen its relationships with healthcare providers.